585 related articles for article (PubMed ID: 15891271)
21. [Myasthenia gravis in Santo Tomás Hospital 1990-1997].
Frago G; Gracia F; Chang E; Andrade Alegre R
Rev Med Panama; 1998 Sep; 23(2):15-9. PubMed ID: 11214554
[TBL] [Abstract][Full Text] [Related]
22. Pediatric Myasthenia Gravis.
Peragallo JH
Semin Pediatr Neurol; 2017 May; 24(2):116-121. PubMed ID: 28941526
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic strategies for myasthenia gravis.
Keys PA; Blume RP
DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
[TBL] [Abstract][Full Text] [Related]
24. Development of novel therapies for MG: Studies in animal models.
Souroujon MC; Brenner T; Fuchs S
Autoimmunity; 2010 Aug; 43(5-6):446-60. PubMed ID: 20298126
[TBL] [Abstract][Full Text] [Related]
25. The immune system, Part 2: Myasthenia gravis.
Stephens A
Nurs Times; 1997 Nov 12-18; 93(46):56-9. PubMed ID: 9418490
[No Abstract] [Full Text] [Related]
26. [Treatment of myasthenia].
Fève JR
Rev Prat; 1988 Oct; 38(22):1541-5. PubMed ID: 3206137
[No Abstract] [Full Text] [Related]
27. [Ocular myasthenia].
Huber A
Klin Monbl Augenheilkd; 1985 Mar; 186(3):158-60. PubMed ID: 3999598
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of myasthenia gravis].
Jerusalem F
Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
[No Abstract] [Full Text] [Related]
30. Current and future therapies for myasthenia gravis.
Yi Q; Lefvert AK
Drugs Aging; 1997 Aug; 11(2):132-9. PubMed ID: 9259176
[TBL] [Abstract][Full Text] [Related]
31. Pearls: myasthenia.
Benatar M
Semin Neurol; 2010 Feb; 30(1):35-7. PubMed ID: 20127579
[TBL] [Abstract][Full Text] [Related]
32. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
33. Myasthenia Gravis.
Gilhus NE
N Engl J Med; 2016 Dec; 375(26):2570-2581. PubMed ID: 28029925
[No Abstract] [Full Text] [Related]
34. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis.
Lagoumintzis G; Zisimopoulou P; Kordas G; Lazaridis K; Poulas K; Tzartos SJ
Autoimmunity; 2010 Aug; 43(5-6):436-45. PubMed ID: 20187712
[TBL] [Abstract][Full Text] [Related]
35. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
Lang AE; Humphrey JG; Gordn DA
J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
[TBL] [Abstract][Full Text] [Related]
36. Myasthenia gravis: emerging new therapy options.
Sieb JP
Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
[TBL] [Abstract][Full Text] [Related]
37. Discordant thymectomy in identical twins concordant for myasthenia gravis.
Riggs KR; Gutmann L; Riggs JE
Ann Intern Med; 2011 Oct; 155(7):478-9. PubMed ID: 21969350
[TBL] [Abstract][Full Text] [Related]
38. Managing patients who have myasthenia gravis.
Johns TR
West J Med; 1985 Jun; 142(6):810-3. PubMed ID: 4024633
[No Abstract] [Full Text] [Related]
39. [Juvenile myasthenia gravis].
Papazian O; Alfonso I
Medicina (B Aires); 2009; 69(1 Pt 1):71-83. PubMed ID: 19240004
[TBL] [Abstract][Full Text] [Related]
40. [Juvenile myasthenia gravis].
Ohno K; Sahashi K
Ryoikibetsu Shokogun Shirizu; 2001; (36):340-3. PubMed ID: 11596404
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
